Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M. Evens, Matthew A. Lunning, Alexey V. Danilov et al.|Blood|2021Cited by 125
Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World AnalysisAdam Zayac, Parameswaran Venugopal, Andrew M. Evens et al.|Blood|2019Cited by 17
Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center StudySwaminathan P. Iyer, Brad M. Haverkos, Tatyana Feldman et al.|Blood|2021Cited by 15